Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yacyshyn

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
The role of gut inflammation in recurrent Clostridium difficile-associated diseaseMary Beth Yacyshyn, Bruce Yacyshyn
Gastro Hep Advances|August 12, 2024
Medicaid Analysis of Substances of Abuse for Patients With Crohn's DiseaseSara E Yacyshyn, Bruce R Yacyshyn
Current Treatment Options in Gastroenterology|November 30, 2000
Fulminant Ulcerative ColitisWong, Yacyshyn
Current Opinion in Molecular Therapeutics|November 21, 2001
The clinical experience of antisense therapy to ICAM-1 in Crohn's diseaseB Yacyshyn, M B Bowen-Yacyshyn, W Shanahan
Evidence-Based Cardiovascular Medicine|December 29, 2005
Verapamil improved walking distance in patients with claudicationV Yacyshyn
Diabetes, Obesity & Metabolism|October 18, 2018
Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT)Patrick Lee, Bruce R Yacyshyn, Mary B Yacyshyn
Gastroenterology & Hepatology|December 6, 2016
Pathophysiology of Clostridium difficile-Associated DiarrheaBruce Yacyshyn
Human Immunology|August 10, 1999
Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitisB Yacyshyn, W Maksymowych, M B Bowen-Yacyshyn
Inflammatory Bowel Diseases|September 26, 2008
Adhesion molecule therapeutics in IBDBruce R Yacyshyn
Digestive Diseases and Sciences|December 1, 1996
Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeabilityB Yacyshyn, J Meddings, D Sadowski, et al.
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
The role of gut inflammation in recurrent Clostridium difficile-associated diseaseMary Beth Yacyshyn, Bruce Yacyshyn
Gastro Hep Advances|August 12, 2024
Medicaid Analysis of Substances of Abuse for Patients With Crohn's DiseaseSara E Yacyshyn, Bruce R Yacyshyn
Current Treatment Options in Gastroenterology|November 30, 2000
Fulminant Ulcerative ColitisWong, Yacyshyn
Current Opinion in Molecular Therapeutics|November 21, 2001
The clinical experience of antisense therapy to ICAM-1 in Crohn's diseaseB Yacyshyn, M B Bowen-Yacyshyn, W Shanahan
Evidence-Based Cardiovascular Medicine|December 29, 2005
Verapamil improved walking distance in patients with claudicationV Yacyshyn
Diabetes, Obesity & Metabolism|October 18, 2018
Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT)Patrick Lee, Bruce R Yacyshyn, Mary B Yacyshyn
Gastroenterology & Hepatology|December 6, 2016
Pathophysiology of Clostridium difficile-Associated DiarrheaBruce Yacyshyn
Human Immunology|August 10, 1999
Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitisB Yacyshyn, W Maksymowych, M B Bowen-Yacyshyn
Inflammatory Bowel Diseases|September 26, 2008
Adhesion molecule therapeutics in IBDBruce R Yacyshyn
Digestive Diseases and Sciences|December 1, 1996
Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeabilityB Yacyshyn, J Meddings, D Sadowski, et al.
Pageof 18